Table of Contents
International Journal of Molecular Imaging
Volume 2013, Article ID 279872, 9 pages
Research Article

-NOTA-CHSg and -CHSg Labeled Microspheres for Lung Perfusion and Liver Radiomicrospheres Therapy Planning

1Biomedical Engineering Department, Florida International University, 10555 West Flagler Street, EC 2614, Miami, FL 33174, USA
2Herbert Wertheim College of Medicine, Florida International University, 1240 SW 108 Avenue, Path, University Park, FL 33174, USA
3Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, USA
4Jackson North Medical Center, 160 NW 170th Street, North Miami Beach, FL 33169, USA

Received 12 September 2013; Revised 11 November 2013; Accepted 18 November 2013

Academic Editor: Adriaan A. Lammertsma

Copyright © 2013 Alejandro Amor-Coarasa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Chandra, J. Shamoun, P. Braunstein, and O. L. DuHov, “Clinical evaluation of an instant kit for preparation of 99mTc MAA for lung scanning,” The Journal of Nuclear Medicine, vol. 14, no. 9, pp. 702–705, 1973. View at Google Scholar · View at Scopus
  2. W. D. Tucker, M. W. Greene, A. J. Weiss et al., Transactions of the 4th Annual Meeting American, Academic Press, New York, NY, USA, 1958.
  3. G. Subramanian, B. A. Rhodes, J. F. Cooper, and V. J. Sodd, Radiopharmaceuticals: International Symposium on Radiopharmaceuticals, Society of Nuclear Medicine, 1975.
  4. L. Brannon-Peppas, “Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery,” International Journal of Pharmaceutics, vol. 116, no. 1, pp. 1–9, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. S. A. Gulec, G. Mesoloras, W. A. Dezarn, P. McNeillie, and A. S. Kennedy, “Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio,” Journal of Translational Medicine, vol. 5, article no. 15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Stevanović, T. Maksin, J. Petković, M. Filipi, and D. Uskoković, “An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres,” Nanotechnology, vol. 20, no. 33, Article ID 335102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. L. Ergün, M. T. Ercan, H. Selek et al., “Evaluation of 99mTc labelled poly lactic acid microspheres for diagnostic radioembolization,” Journal of Microencapsulation, vol. 17, no. 4, pp. 509–518, 2000. View at Google Scholar · View at Scopus
  8. H.-S. Bom, J.-J. Min, and H.-J. Jeong, “Molecular nuclear imaging for targeting and trafficking,” Nuclear Engineering and Technology, vol. 38, no. 5, pp. 399–404, 2006. View at Google Scholar
  9. “Chitosan microspheres: therapeutic agent for liver-directed radiomicrosphere therapy,” The Journal of Nuclear Medicine, vol. 53, supplement 1, article 1707, 2012.
  10. M. N. V. R. Kumar, R. A. A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A. J. Domb, “Chitosan chemistry and pharmaceutical perspectives,” Chemical Reviews, vol. 104, no. 12, pp. 6017–6084, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Riva, H. Ragelle, A. des Rieux, N. Duhem, C. Jérôme, and V. Préat, “Chitosan and chitosan derivatives in drug delivery and tissue engineering,” Advances in Polymer Science, vol. 244, no. 1, pp. 19–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Even and M. A. Green, “Gallium-68-labeled macroaggregated human serum albumin, 68Ga-MAA,” International Journal of Radiation Applications and Instrumentation, vol. 16, no. 3, pp. 319–321, 1989. View at Google Scholar · View at Scopus
  13. A. A. Coarasa, A. Milera, D. A. Carvajal, and A. J. McGoron, “99mTc-MAA versus 68Ga-MAA as Perfusion Agents,” in Proceedings of the 29th Southern Biomedical Engineering Conference (SBEC '13), Miami, Fla, USA, May 2013.
  14. S. J. Wagner and M. J. Welch, “Gallium-68 labelling of albumin and albumin microspheres,” The Journal of Nuclear Medicine, vol. 20, no. 5, pp. 428–433, 1979. View at Google Scholar · View at Scopus
  15. M. J. Jae, K. H. Mee, S. C. Young et al., “Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1, 4,7-triacetic acid and feasibility studies in mice,” The Journal of Nuclear Medicine, vol. 49, no. 5, pp. 830–836, 2008. View at Publisher · View at Google Scholar · View at Scopus